ArticleThe journal of allergy and clinical immunology. Global2022

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.

Courtney Crim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.